Please login to the form below

Not currently logged in
Email:
Password:

MHP wins EFPIA account for EU health outcomes campaign

The UK agency will be supported by its Brussels partner cabinetDN

MHPMHP Communications has been appointed by The European Federation of Pharmaceutical Industries and Associations (EFPIA) to run an EU-wide communications programme.

The health outcomes programme will focus on how to achieve sustainable healthcare systems in all EU member states.

Commenting on the project, Con Franklin, director of MHP, said that there is currently “no greater challenge in European healthcare than securing the long-term sustainability of member state health systems”.

Franklin will jointly lead the project alongside Rachel Rowson, head of health at MHP, overseeing a small team in the UK and Brussels and reporting to EFPIA's director of communications, Andy Powrie-Smith.

The campaign will seek to increase the focus on care based on health outcomes which go beyond direct clinical results and consider the individualised needs of patients.

Powrie-Smith welcomed the partnership with MHP saying, “working with MHP allows us to tap in to their undoubted expertise and enthusiasm to deliver a transformational programme of activities”.

Article by
Rebecca Clifford

8th February 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need...
JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...